References
- Geweke J, Weisbrod B A. How does technological change affect health care expenditures? The case of a new drug. Eval Rev 1984; 8: 75–92
- Culyer A J, Maynard A K. Cost-effectiveness of duodenal ulcer treatment. Soc Sci Med 1981; 15C: 3–11
- Carlsson P, Jonsson B. The effects of cimetidine on the cost of ulcer disease in Sweden. Soc Sci Med 1991; 33: 275–82
- Bate C M. Cost effectiveness of omeprazole in the treatment of reflux esophagitis. Br J Med Econom 1991; 1: 53–61
- Bate C M, Richardson P DI. A one-year model for the cost-effectiveness of treating reflux esophagitis. Br J Med Econom 1992; 2: 5–11
- Hillman A, Bloom B, Fendrick A M. Cost and quality effects of alternative treatments for gastroesophageal reflux disease. Arch Intern Med 1992; 152: 1467–72
- Lindberg G, Jonsson B. Omeprazol mer kostnadseffektivt an ranitidin vid refluxesofagit. Lakartidningen 1992; 89: 2530–3
- Sintonen H, Alander V. Comparing the cost-effectiveness of drug regimens in the treatment of duodenal ulcers. J Health Econom 1990; 9: 85–101
- Bate C M, Crowe Dickinson JP. Reflux esophagitis resolves more rapidly with omeprazole 20 mg once daily than with ranitidine 150 mg twice daily: omeprazole 40 mg once daily provides further benefit in unresponsive patients. Br J Clin Res 1991; 2: 133–48
- Beck J R, Pauker S G. The Markov process in medical prognosis. Med Decis Making 1983; 3: 419–58
- Doubilet P, Begg C B, Weinstein M C. Probabilistic sensitivity analysis using Monte Carlo simulation, a practical approach. Med Decis Making 1985; 5: 157–77
- Sonnenberg A. Cost of medical and surgical treatment of duodenal ulcer. Gastroenterology 1989; 96: 1445–52
- Hetzel D J, Dent J, Reed W D. Healing and relapse of severe peptic esophagitis after treatment with omeprazole. Gastroenterology 1988; 95: 903–12
- Sandmark S, Carlsson R, Fausa O. Omeprazole or ranitidine in the treatment of reflux esophagitis. Result of a double-blind, randomized, Scandinavian multicenter study. Scand J Gastroenterol 1988; 23: 625–32
- Hetzel D, Carlsson R, Dent J. Relapse of esophagitis after endoscopic healing, an analysis of unfavourable prognostic factors. Scand J Gastroenterol 1989; 166: 175, Suppl
- Dent J. Australian clinical trials of omeprazole in the management of reflux esophagitis. Digestion 1990; 47(Suppl 1)69–71
- Lundell L, Backman L, Ekstrom P. Omeprazole or high-dose ranitidine in the treatment of patients with reflux esophagitis not responding to ‘standard’ dose of H2 receptor antagonists. Aliment Pharmacol Therap 1990; 4: 145–55
- Eriksson S, Rikner L. Meta-analysis of omeprazole versus ranitidine in acute treatment of duodenal ulcer, gastric ulcer and reflux esophagitis, MölndalSweden, 1990, Working paper, AB Astra, AB Hassle
- Zeitoun P, Rampal P, Barbier P. Omeprazole (20 mg/j) comparé à ranitidine (150 mg 2 fois/j) dans le traitement de l'æophagite par reflux. Résultats d'un essai multicentrique franco-beige, randomise en double insu. Gastroenterol Clin Biol 1989; 13: 457–62
- Blum A, Wienbeck M, Schiessel R. Omeprazole is superior to ranitidine in the treatment of reflux esophagitis. Hepato-gastroenterology 1989; 36: 279
- Johannesson M, Borgquist L, Elenstal A. Läkemedels-och konsultationskostnad för behandling vid en vårdcentral. CMT Rapport, 1990:1. Center for Medical Technology Assessment, Linkóping 1990